Home / News / FAQ
FAQ

Nutriband Inc. (NASDAQ: NTRB) 25% Preferred Stock Dividend FAQ

FaqStaq News - Just the FAQs • July 18, 2025
By FAQstaq Staff
Read Original Article →
Nutriband Inc. (NASDAQ: NTRB) 25% Preferred Stock Dividend FAQ

Summary

Nutriband Inc. announces a 25% preferred stock dividend for shareholders of record by July 25, 2025, payable on August 5, with each preferred share convertible to common stock upon FDA approval of its AVERSA Fentanyl product.

What is the Nutriband Inc. 25% preferred stock dividend about?

Nutriband Inc. is offering a 25% preferred stock dividend, where shareholders of record as of July 25, 2025, will receive one preferred share for every four common shares held, payable on August 5, 2025.

How can preferred shares be converted to common shares?

Each preferred share will be convertible to one common share upon FDA approval of Nutriband’s AVERSA Fentanyl product.

What happens to unconverted preferred shares?

Unconverted preferred shares will be eligible for annual cash dividends from company profits at the discretion of the board.

Who is eligible for the Nutriband Inc. preferred stock dividend?

Shareholders of record as of July 25, 2025, are eligible for the preferred stock dividend.

When is the Nutriband Inc. preferred stock dividend payable?

The dividend is payable on August 5, 2025.

What is Nutriband Inc.’s lead product under development?

Nutriband’s lead product under development is an abuse-deterrent fentanyl patch incorporating its AVERSA(TM) abuse-deterrent technology.

Where can I find more information about Nutriband Inc.?

For more information about Nutriband Inc., visit www.Nutriband.com.

How can I stay updated on Nutriband Inc. news?

The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB.

What is BioMedWire?

BioMedWire is a specialized communications platform focusing on the latest developments in the Biotechnology, Biomedical Sciences, and Life Sciences sectors, part of the Dynamic Brand Portfolio @ IBN.

How can I receive SMS alerts from BioMedWire?

To receive SMS alerts from BioMedWire, text ‘Biotech’ to 888-902-4192 (U.S. Mobile Phones Only).

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)

Article Control ID: 108724